Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021030571 - METHODS OF TREATING PSYCHOLOGICAL AND BRAIN DISORDERS

Publication Number WO/2021/030571
Publication Date 18.02.2021
International Application No. PCT/US2020/046149
International Filing Date 13.08.2020
IPC
A61K 31/4045 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
C07D 209/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
A61K 31/675 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
675having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61P 25/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
Applicants
  • UNIVERSITY OF MARYLAND, BALTIMORE [US]/[US] (AllExceptUS)
  • THOMPSON, Scott [US]/[US] (US)
Inventors
  • THOMPSON, Scott
Agents
  • ADLER, Benjamin, Aaron
Priority Data
62/886,09013.08.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS OF TREATING PSYCHOLOGICAL AND BRAIN DISORDERS
(FR) MÉTHODES DE TRAITEMENT DE TROUBLES PSYCHOLOGIQUES ET CÉRÉBRAUX
Abstract
(EN)
Provided herein are methods for preventing or treating a psychological disorder. A serotonin agonist or an agonist of serotonin receptors is administered separately, sequentially or simultaneously in combination with a serotonin receptor 2A antagonist.
(FR)
L'invention concerne des procédés de prévention ou de traitement d'un trouble psychologique. Un agoniste de la sérotonine ou un agoniste des récepteurs de la sérotonine est administré séparément, séquentiellement ou simultanément en combinaison avec un antagoniste du récepteur 2A de la sérotonine.
Latest bibliographic data on file with the International Bureau